Hims & Hers' Chief Policy Officer Files Insider Transaction
Deborah M. Autor, chief policy officer at Hims & Hers Health (NASDAQ: HIMS), sold 16,147 shares on August 14 to cover tax liabilities from the vesting of restricted stock units. The transaction was non-discretionary and part of a broader pattern involving other executives around that time. Autor now holds approximately 65,734 directly owned shares with an estimated value of $1.9 million at the post-transaction market price. She also retains derivative securities totaling over 427,000 unvested awards, aligning her long-term incentives with shareholder performance. The stock had declined by nearly 38% in the preceding year. Hims & Hers reported $2.6 billion in trailing twelve-month revenue and a net loss of $142 million during that period. It faces regulatory challenges from both the FTC, which filed a lawsuit on July 29 over data-sharing practices, and the FDA regarding peptide compound rulemaking.
Tickers: $HIMS
Topics: executive compensation Hims & Hers Health stock disposition